Cardiac Transplant Outcomes in Pediatric Patients with Pre-formed Anti-Human Leukocyte Antigen Antibodies and/or Positive Retrospective Crossmatch

Journal of Heart and Lung Transplantation

Volumn 26, Issue 11, 2007, Pages 1163-1169

  Wright, Eric J ^a   Fiser, William P ^a   Edens, R Erik ^b   Frazier, Elizabeth A ^b   Morrow, W Robert ^b   Imamura, Michiaki ^a   Jaquiss, Robert D B ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ARTICLE; CARDIOMYOPATHY; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, ANTI-IDIOTYPIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART DISEASES; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 36048948929     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.07.042     Document Type: Article

References (28)

1. Mehra M.R., Uber P.A., Uber W.E., Scott R.L., and Park M.H. Allosensitization in heart transplantation: implications and management strategies. Curr Opin Cardiol 18 (2003) 153-158
2. Thompson J.S., Thacker II L.R., and Takemoto S. The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry. Transplantation 69 (2000) 2178-2186
3. Kobashigawa J.A., Sabad A., Drinkwater D., et al. Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation?. Circulation 94 9 suppl (1996) II294-II297
4. Tambur A.R., Bray R.A., Takemoto S.K., et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection. Transplantation 70 (2000) 1055-1059
5. Ratkovec R.M., Hammond E.H., O'Connell J.B., et al. Outcome of cardiac transplant recipients with a positive donor-specific crossmatch--preliminary results with plasmapheresis. Transplantation 54 (1992) 651-655
6. Smith J.D., Danskine A.J., Laylor R.M., Rose M.L., and Yacoub M.H. The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantation. Transpl Immunol 1 (1993) 60-65
7. Loh E., Bergin J.D., Couper G.S., et al. Role of panel reactive antibody crossreactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transplant 13 (1994) 194-20
8. John R., Rajasinghe H., Chen J.M., et al. Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients. Ann Surg 232 (2000) 302-311
9. Aziz S., Hassantash S.A., Nelson K., et al. The clinical significance of flow cytometry crossmatching in heart transplantation. J Heart Lung Transplant 17 (1998) 686-692
10. Bishay E.S., Cook D.J., Starling R.C., et al. The clinical significance of flow cytometry crossmatching in heart transplantation. Eur J Cardiothorac Surg 17 (2000) 362-369
11. Betkowski A.S., Graff R., Chen J.J., et al. Panel-reactive antibody screening practices prior to heart transplantation. J Heart Lung Transplant 21 (2002) 644-650
12. Alsoufi B., Bennetts J., Verma S., and Caldarone C.A. New developments in the treatment of hypoplastic left heart syndrome. Pediatrics 119 (2007) 109-117
13. Duncan B.W. Pediatric mechanical circulatory support in the United States: past, present, and future. ASAIO J 52 (2006) 525-529
14. Hooper D.K., Hawkins J.A., Fuller T.C., Profaizer T., and Shaddy R.E. Panel-reactive antibodies late after allograft implantation in children. Ann Thorac Surg 79 (2005) 641-644 discussion 645
15. Gebel H.M., and Bray R.A. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 69 (2000) 1370-1374
16. Bray R.A., Nickerson P.W., Kerman R.H., and Gebel H.M. Evolution of HLA antibody detection: technology emulating biology. Immunol Res 29 (2004) 41-54
17. Zangwill S.D., Ellis T.M., Zlotocha J., et al. The virtual crossmatch-a screening tool for sensitized pediatric heart transplant recipients. Pediatr Transplant 10 (2006) 38-41
18. Leffell M.S., Montgomery R.A., and Zachary A.A. The changing role of antibody testing in transplantation. Clin Transpl (2005) 259-271
19. Stewart S., Winters G.L., Fishbein M.C., et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24 (2005) 1710-1720
20. Jacobs J.P., Quintessenza J.A., Boucek R.J., et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann. Thorac Surg 78 (2004) 1703-1709
21. Casarez T.W., Perens G., Williams R.J., et al. Humoral rejection in pediatric orthotopic heart transplantation. J Heart Lung Transplant 26 (2007) 114-119
22. Chartrand C., Servando E.S., and Chartrand S. Risk factors for acute rejection after pediatric heart transplantation. Transplant Proc 33 (2001) 1732-1734
23. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8 (1989) 430-443
24. Lones M.A., Czer L.S., Trento A., Harasty D., Miller J.M., and Fishbein M.C. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. J Heart Lung Transplant 14 (1995) 151-162
25. Michaels P.J., Espejo M.L., and Kobashigawa J. Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58-69
26. Di Filippo S., Girnita A., Webber S.A., et al. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum Immunol 66 (2005) 513-518
27. Tambur A.R., Pamboukian S.V., Costanzo M.R., et al. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation 80 (2005) 1019-1025
28. Xydas S., Yang J.K., Burke E.M., et al. Utility of post transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 1289-1296